Congenital Deafness

Last updated May 26, 2003

While acquired deafness associated with age or noise exposure more common than genetic deafness by roughly 2 orders of magnitude, congenital deafness occurs in 1 per every 1000-2000 births with autosomal recessive inheritance being the most common form (more than 75%).  Non-inherited abnormalities of the inner ear such as the Mondini malformation, account for roughly 20% of congenital sensorineural deafness. The bulk of the remaining, genetic deafness is non-syndromic, meaning that it does not have any obvious distinguishing features.

Non-syndromic (80% of congenital deafness):

About 80% of genetic hearing loss is non-syndromic. Between 1992 and 2001, 38 loci for autosomal dominant nonsyndromic deafness have been mapped and 11 genes have been cloned. Autosomal dominant locii are called DFNA, autosomal recessive as DFNB, and X-linked as DFN. An update on current locii can be found on the hereditary hearing loss homepage, which is hosted by the University of Iowa. Non-syndromic deafness is highly heterogeneous but mutations in the connexin-26 molecule (gap junction protein, gene GJB2) account for about 49% of patients with non-syndromic deafness and about 37% of sporadic cases. Assays for connexin-26 are commercially available at several laboratories. About 1 in 31 individuals of European extraction are likely carriers. However, population analysis suggests that there are over 100 genes involved in non-syndromic hearing impairment (Morton, 1991). One mutation is particularly common, namely the 30delG.

There is a nomenclature for the nonsyndromic deafness:

Autosomal dominant (DFNA)

Autosomal dominant deafness is passed directly through generations. It is often possible to identify an autosomal dominant pattern through simple inspection of the family tree. Examples of autosomal dominant deafness are missense mutation in COL11A2 (DFNA13) (Leenheer et al, 2001). COL11A2 encodes a chain of type XI collagen. As an example of a deafness phenotype, in DFNA10 results in a postlingual, initially progressive, and resulting, without the influence of presbycusis, in largely stable, flat sensorineural deafness (De Leenheer et al, 2001).

De Leenheer EM, Huygen PL, Wayne S, Smith RJ, Cremers CW. The DFNA10 phenotype.Ann Otol Rhinol Laryngol 2001 Sep;110(9):861-6

Autosomal Recessive (DFNB)

Autosomal recessive disorders require a gene from both the mother and father.

 

Syndromic deafness (The remaining 20% of congenital deafness)

These are an immensely complicated interlinked set of disorders. The descriptions here are only to give the general flavor of the diseases and are not meant to include all features of the disorders. In most cases an OMIM database link to the main type of the genetic disorder is provided.

Alport syndrome

Alport syndrome is caused by mutations in COL4A3, COL4A4 or COL4A5. The classic phenotype is renal failure and progressive sensorineural deafness.

Branchio-Oto-Renal Syndrome, and also see HERE

Branchio-oto-renal syndrome is caused by mutations in EYA1, a gene of 16 exons within a genomic interval of 156 kB. This syndrome is characterized by hearing disturbances and cataract, branchial cleft fistulae, and preauricular pits. Mondini malformations and related dysplasias may occur.

X-linked Charcot Marie Tooth.

The dominantly form of X-linked CMT is caused by a mutation in the connexin 32 gene mapped to the Xq13 locus. Usual clinical signs consist of a peripheral neuropathy combined with foot problems and "champagne bottle" calves. Sensorineural deafness occurs in some. (Stojkovic and others, 1999).

As noted above, the connexin gene is also associated with a large percentage of cases of non-syndromic deafness. There are several other associated neuropathies and deafness syndromes. Autosomal recessive demyelinating neuropathy, autosomal dominant hereditary neuropathies type I and II, and X-linked hereditary axonal neuropathies with mental retardation are all associated with deafness (Stojkovic and others, 1999).

Goldenhar's syndrome.

Oculoauriculovertebral dysplasia (OAVD) or Goldenhar's syndrome was originally described in 1881. It includes a complex of features including hemifacial microtia, otomandibar dysostosis, epibulbar lipodermoids, coloboma, and vertebral anomalies that stem from developmental vascular and genetic field aberrations. It has diverse etiologies and is not attributed to a single genetic locus. The incidence is roughly 1 in 45,000. (Scholtz et al, 2001).

Jervell and Lange-Nielsen Syndrome

This syndrome is associated with cardiac arrhythmias There is by prolongation of the QT interval, torsade de pointe arrhythmias (turning of the points, in reference to the apparent alternating positive and negative QRS complexes), sudden syncopal episodes, and severe-to-profound sensorineural hearing loss.

 

Mohr-Tranebjaerg syndrome (DFN-1)

Mohr-Tranebjaerg syndrome (DFN-1) is an X-linked recessive syndromic hearing loss characterized by postlingual sensorineural deafness in childhood followed by progressive dystonia, spasticity, dysphagia and optic atrophy. The syndrome is caused by a mutation thought to result in mitochondrial dysfunction. It resembles a spinocerebellar degeneration called Fredreich's ataxia which also may exhibit sensorineural hearing loss, ataxia and optic atrophy. The cardiomyopathy characteristic of Freidreichs is not seen in Mohr-Tranebjaergt.

 

Norrie Disease.

Classic features include specific ocular symptoms (pseudotumor of the retina, retinal hyperplasia, hypoplasia and necrosis of the inner layer of the retina, cataracts, phthisis bulbi), progressive sensorineural hearing loss, and mental disturbance, although less than one-half of patients are hearing impaired or mentally retarded.

Pendred Syndrome

Deafness is associated with thyroid disease (goiter).

Stickler syndrome.

Mutations in COL11 are the cause in Stickler syndrome. This syndrome is characterized by hearing impairment, midface hypoplasia, progressive myopia in the first year of life and arthropathy.

Treacher Collins Syndrome (OMIM Entry TCOF1)

Treacher Collins syndrome is characterized by coloboma of the lower eyelid (the upper eyelid is involved in Goldenhar syndrome), micrognathia, microtia, hypoplasia of the zygomatic arches, macrostomia, and inferior displacement of the lateral canthi with respect to the medial canthi.

Waardenburg syndromes type I and II

The clinical symptoms of Waardenburg Syndrome (WS) include lateral displacement of the inner canthus of each eye, pigmentary abnormalities of hair, iris, and skin (often white forelock and heterochromia iridis), and sensorineural deafness. The combination of WS type I characteristics with upper limb abnormalities has been called Klein-Waardenburg syndrome or WS type III. The combination of recessively inherited WS type II characteristics with Hirschsprung disease has been called Waardenburg-Shah syndrome or WS type IV.

Ushers syndrome.

Usher syndrome is characterised by hearing impairment and retinitis pigmentosa. Usher syndrome can be classified into 3 different types on the basis of clinical findings. In type one, there is both hearing impairment and vestibular impairment. In type II, there is hearing impairment without vestibular impairment. In type three, there is variable amounts of vestibular impairment.

 

Mitochondrial disorders.

This topic was recently reviewed (Edmonds et al, 2002). Mitochondrial disorders usually first manifest in tissues with high metabolic demands such as nerve and muscle. Similarly the complete auditory pathway is at risk from mitochondrial disorders. Hearing loss is common in mitochondrial disorders including MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke like episodes), Kearns-Sayre syndrome (KSS) and MERRF (myoclonic epilepsy with ragged red fibers). Others include complex I deficiency, cytochrome-c oxidase (complex IV) deficiency or COX, pyruvate dehydrogenase deficiency (PDH). These disorders are caused by mutations in mitochondrial DNA, and are characterized by muscular weakness, an abnormal muscle biopsy with "ragged red" fibers, and a lactic acidosis. Edmonds et al found that 80% of persons with severe mitochondrial disease had hearing deficits. They suggested that these patients are more vulnerable than others to bacterial infection and should be managed more aggressively than the general population. This conclusion must be looked at with caution as some antibiotics may have their site of action on mitochondria, which resemble bacteria in many ways.

In MELAS, Sue et al recently reported that the hearing loss is caused by cochlear damage. It resembles presbyacusis in that it is generally symmetrical, gradual, and affects the higher frequencies first (Sue et al, 1998). Edmonds et al (2002) suggested that lesions might also occur elsewhere in the auditory pathway.

Others have also reported hearing loss associated with mitochondrial mutations (Yamasoba et al, 1999; Tsutsumi et al, 2001). Mitochondrial DNA mutations accumulate naturally during life and are presently implicated as an important cause of normal aging.

Patients with Kearns-Sayre syndrome were found to have a significantly prolonged I-V ABR latency in one study (Nakamura et al, 1995)

Mitochondrial defects including a deletion in A1555G have been reported to both cause unusual sensitivity to aminoglycosides as well as nonsyndromic sensorineural deafness (El-Schahawi et al, 1997 -- this paper reviews "mitochondrial deafness). These patients have a mild high-frequency sensorineural hearing loss without aminoglycoside exposure.

Mohr-Tranebjaerg syndrome (DFN-1) is also thought to cause deafness via a mitochondrial disturbance.

An update on current locii can be found on the hereditary hearing loss homepage, which is hosted by the University of Iowa. Labs that do testing for mitochondrial as well as other genetic disorders are listed here.

 


Non-Inherited Congenital Deafness

These types of abnormalities account for roughly 20% of congenital deafness, the remainder being genetic in origin.

Viral syndromes

Congenital hearing loss is often attributed to prenatal infections with neurotrophic viruses such as measles or cytomegalovirus (CMV). A recent study suggested that "more than 40% of deafness of unknown cause, needing rehabilitation" is attributed to CMV. (Barbi et al, 2003)

Mondini and Michel dysplasiamondini  from Strome et al.

The normal cochlea has two and one-half turns. A cochlear malformation consists of a membranous  abnormality, a bony abnormality, or a combination of these two. If cochlear development is arrested in the embryo, a common cavity may occur instead of the snail like cochlea. A complete labyrinthine and cochlelar aplasia is called the Michel deformity. An incomplete partition is called the Mondini dysplasia or malformation. This furthermore consists of a cystic apex, a dilated vestibule and a large vestibular aqueduct (see below). An example of a high-resolution CT scan of a Mondini malformation  is shown on the right (Strome et al, 1998). The black arrow shows a sac-like cochlea. The white arrow shows an amorphous vestibule without any defined semicircular canals. There are various other variant malformations including cochlear aplasia and hypoplasia, as well as others (Sennaroglu and Saatci, 2002)

Often accompanying the Mondini dysplasia is abnormal communication between the endolymphatic and perilymphatic spaces of the inner ear and subarachnoid space. It is usually caused by a defect in the cribiform area of the lateral end of the internal auditory canal.  Presumably because of this abnormal channel, perilymphatic fistulae are more common in this disorder.

CT scans are not able to define abnormalities of the membranous labyrinth, but high-resolution MRI has been used to visualize these structures. Practically however, at this writing (2003), conventional 1.5 tesla MRI scanners do not provide enough detail to be of much clinical value.

A related anomaly and more severe syndrome, the CHARGE association consists of coloboma, heart disease, choanal atresia, retarded development, genital hypoplasia, ear anomalies including hypoplasia of the external ear and hearing loss. These individuals have a Mondini type deformity and absence of semicircular canals. A recent report documents that they have normal otolithic responses to off-vertical axis rotation (Wiener-Vacher et al, 1999).

Enlarged Vestibular Aqueduct syndromesd

First described by Valvassori, enlargement is defined on the CT scan as a diameter greater to or equal to 1.5 mm measured midway between the operculum and the common crus. According to Murray et al (2000), coronal CT scan is the best view for evaluating it in children. Enlarged vestibular aqueducts can also be seen on high-resolution MRI. It may cause a fluctuating sensorineural hearing loss. Conservative management, including avoidance of head trauma and contact sports, has been the mainstay of treatment. Surgery to close the enlarged structure frequently results in significant hearing loss (Welling et al, 1999).

 


References:

  1. Barbi M, Binda S, Caroppo S, Ambrosetti U, Corbetta C, Sergi P. A wider role for congenital cytomegalovirus infection in sensorineural hearing loss. Pediatr Infect Dis J 2003 Jan;22(1):39-42
  2. Edmonds JL and others. The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection. Arch Otolaryngol HNS 2002;128:355-362
  3. El-Schahawi M, and others. Two large spanish pedigrees with nonsyndromic sensorineural deafness and the mtDNA mutation at nt 1555 in the 12S rRNA gene. Evidence of heteroplasmy. Neurology 1997;48:453-
  4. Scholtz et al. Goldendar's syndrome: congential hearing deficit of conductive or sensorineural origin ? Otology Neurotol 22:501-505, 2001
  5. Leenheer and others. Autosomal dominant inherited hearing impairment caused by a missense mutation in COLA11A2 (DFNA13).
  6. Merchant SN and others. Temporal bone histopathologic and genetic studies in Mohr-Tranebjaert Syndrome (DFN-1). Otol Neurotol 22:506-511, 2001
  7. Morton NE. 1991. Genetic epidemiology of hearing impairment. Ann NYAS 630;16-31.
  8. Murray N, Tanaka J, Cameron D, Gianoli G. Coronal computed tomography of the normal vestibular aqueduct in children and young adults. Arch Otolaryngol HNS 2000:126:1351-1357
  9. Nakamura Y and others. Abnormal evoked potentials of Kearns-Sayre syndrome. Electromyogr Clin Neurophysiol 1995:35:365-370
  10. Sennaroglu L, Saatci I. A new classification for cochleovestibular malformations. Laryngoscope 112:2230-2241, 2002
  11. Sue CM and others. Cochlear origin of hearing loss in MELAS syndrome. Ann Neurol 1998:43:350-59.
  12. Steel KP. A new era in the genetics of deafness. NEJM 1998
  13. Stojkovic and others. Sensorineural defaness in X-linked Charcot-Marie-Tooth disease with connexin 32 mutation (R142Q). Neurology 1999:52:1010-1014
  14. Strome SE, Baker KB, Langman AW. Imaging case of the month: Inner ear malformation. American J. Otology, 19:396-397, 1998
  15. TSUTSUMI T, Nishida H, Noguchi Y, Komatsuzaki A, Kitamura K. Audiological findings in patients with myoclonic epilepsy associated with ragged-red fibres. J Laryngol Otol 2001; 115: 777-81.
  16. Welling B, and tothers. Sensorineural hearing loss after occlusion of the enlarged vestibular aqueduct. Am J. Otol 20:338-343, 1999
  17. Wiener-Vacher SR, Denise P, Narcey P, Manach Y. Vestibular function in children with the CHARGE association. Arch Otolaryngol HNS 1999:125:342-34
  18. Yamasoba and others.Cochlear histopathology associated with mitochondrial transfer RNA (leu-UUR) gene mutation. Neurology 1999:52;1705-1707